Epstein-Barr virus: An important vaccine target for cancer prevention

Jeffrey I. Cohen, Anthony S. Fauci, Harold Varmus, Gary J. Nabel

Research output: Contribution to journalArticlepeer-review

191 Scopus citations


Participants at the February 2011 meeting at the U.S. National Institutes of Health on Epstein-Barr virus (EBV) vaccine research recommend that future clinical trials have two goals: prevention of infectious mononucleosis and EBV-associated cancers, facilitated by identification of disease-predictive surrogate markers.

Original languageEnglish (US)
Article number107fs7
JournalScience Translational Medicine
Issue number107
StatePublished - Nov 2 2011
Externally publishedYes

ASJC Scopus subject areas

  • General Medicine


Dive into the research topics of 'Epstein-Barr virus: An important vaccine target for cancer prevention'. Together they form a unique fingerprint.

Cite this